Svoboda Capital Partners agrees financial partnership with 120/80 Health Group
New York communications and strategy consultancy focused on healthcare and life sciences agrees terms on a financial partnership with Chicago-based Svoboda Capital.
120/80 Health Group has agreed to terms on a financial partnership with Svoboda Capital Partners LLC, a Chicago-based private equity firm, according to a November 2, 2026 press release. Financial terms were not disclosed.
120/80 Health Group was founded in 2018 and is headquartered in New York City. It began as a communications firm for early-stage digital health startups and now provides strategic consulting to companies from pre-Series A to publicly traded businesses, with an exclusive focus on healthcare and life sciences.
Founder and CEO Rob Cronin said Svoboda shares the firm's view that technology, AI and new care models can make care more accessible. Svoboda managing director Will King said the partnership builds on the firm's work with other strategic communications and advisory firms, and that the investment is intended to fund growth while preserving culture.
Deal facts
- Target
- 120/80 Health Group
- Business
- New York-based communications and strategic consultancy serving healthcare and life sciences companies
- Investor
- Svoboda Capital Partners
- Sponsor
- Svoboda Capital Partners
- Deal type
- Investment
- Headquarters
- New York, New York
- Status
- Announced
- Announced
- Monday, November 2, 2026
Sources
- PR Newswire via Yahoo FinanceNov 2, 2026
- Private Equity ProfessionalNov 9, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.